- Home
- Equipment
- north korea
- drug developers
Refine by
Drug Developers Equipment & Supplies In North Korea
127 equipment items found
by:Verb Biotics based inBoston, MASSACHUSETTS (USA)
Yso3 is a preclinical drug development program aimed at treating asthma. Using a revolutionary form of living biotherapy targeting the lung, YSOPIA is pioneering the innovative field of the lung microbiome. As part of this program, YSOPIA has selected a clinical candidate having demonstrated strong in vivo efficacy on inflammation and lung functions. We have ...
Manufactured by:Cytocast based inBudapest, HUNGARY
Cytocast is at the forefront of medical technology with its innovative Cytocast Digital Twin Platform™, a pioneering solution in drug development and personalized medicine. At its core is the CYTOCAST DIGITAL TWIN Cell™, a highly detailed simulated human cell model encompassing 15 tissue types. The platform integrates multi-omics data and ...
Manufactured by:BUHLMANN Diagnostics Corp based inAmherst, NEW HAMPSHIRE (USA)
Flow CAST® Support in Drug Development: Inhibition of Basophil Activation is a Surrogate Biomarker for the Activity of Kinase ...
Manufactured by:Ardigen based inKraków, POLAND
Bioinformatics Analysis & Drug Discovery in the era of Artificial Intelligence. The digital CRO team brings together scientists and engineers with diverse skill sets, ranging from biology and chemistry to statistics and machine learning. We work with both small startups and big pharmas to leverage digital power in order to enable the development of new ...
by:KoBioLabs based inGwanak-ro, Gwanak-gu, SOUTH KOREA
New Drug Development Focusing on Immune/Metabolic/Neurological. ...
Manufactured by:Gesynta Pharma AB based inStockholm, SWEDEN
The drug candidate GS-659, which is sprung from Gesynta Pharma’s drug development platform, is currently in preclinical development phase. Project updates will be announced in due ...
Manufactured by:SiO2 Materials Science based inAuburn, ALASKA (USA)
We provide a common drug contact surface starting at the research and pre-clinical drug development phases, through clinical trials, and on through to commercial ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
Agonist refers to substances that activate a specific target protein. It can easily be viewed as the opposite of inhibitor. Until now, Deargen's drug-target interaction (DTI) was predicted based on the binding affinity between the substance and the target protein, which causes barrier to distinguish between the inhibition and activation activity. In addition, the demand for ...
Manufactured by:SiO2 Materials Science based inAuburn, ALASKA (USA)
We provide a common drug contact surface starting at the research and pre-clinical drug development phases, through clinical trials, and on through to commercial ...
Manufactured by:Troikaa Pharmaceuticals Ltd. based inAhmedabad, INDIA
To provide therapeutically meaningful extended delivery of drugs, Troikaa has developed Duo Phase Technology. Through this technology, the drug dose is split judiciously into two components, where one part delivers the drug immediately and the other releases the drug in a sustained release pattern. Thus ...
Manufactured by:PeptaNova GmbH based inSandhausen, GERMANY
This particular peptide, available in 1mg packages, is intended strictly for laboratory research and must not be utilized for drug development purposes. Researchers employing this peptide gain an advantage in studying fructosylation reactions, contributing to a deeper understanding of the molecular pathways affected in various metabolic ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
PROTAC is composed of a protein of interest, a ligand that binds to the E3 ligase, and a linker that connects the two. PROTAC is emerging as a next-generation platform for new drug development that overcomes the problems of drug resistance and “Undruggable targets” of existing target therapies whose main purpose was to inhibit the ...
Manufactured by:Allevi, Inc. based inPhiladelphia, PENNSYLVANIA (USA)
Clinically relevant drug-drug interactions (DDI) are a serious concern for any new drug development project. To better support capturing the multiple mechanisms of DDI potential using primary hepatocytes, we now offer Interaction Qualified Human Hepatocytes (Catalog HUCPI) which are characterized for 3 major mechanisms of DDI: ...
Manufactured by:Virica Biotech based inOttawa, ONTARIO (CANADA)
Gene therapies and vaccines save and protect human life. The COVID-19 pandemic highlights the criticality of vaccine development today and into the future. The pandemic also highlights the challenges drug developers and manufacturers face. To achieve meaningful yields of viral medicines, you rely on living cells, grown at scale, in specialized ...
by:Orion Biotechnology Canada, Ltd. based inOttawa, SWITZERLAND
G Protein-Coupled Receptors (GPCRs) are involved in a wide range of physiological and pathological processes and represent a large class of drug targets accounting for >30% of all drugs on the market. These drugs, however, only cover 15% of the entire GPCR family, and many valuable receptors remain undrugged. In particular, GPCRs whose natural ...
Manufactured by:SCHOTT Pharma based inMainz, GERMANY
EVERIC® pure vials, crafted by SCHOTT Pharma, are designed for optimal drug formulation protection. These vials address typical concerns seen with conventional glass vials such as elevated leachable levels, pH alterations, and delamination risks. Constructed from advanced borosilicate glass tubing, they provide enhanced hydrolytic resistance and a uniform inner surface. This ...
Manufactured by:Ncardia Services B.V. based inLeiden, NETHERLANDS
Fluorescence-based assays with iPSC-derived cardiac and neuronal models can be used to monitor short and long-term drug-induced changes on calcium transients. Our scientists develop the most optimal calcium transient assay for each project and can scale it up for high-throughput screening, to accurately evaluate efficacy and safety of drug ...
Manufactured by:Montana Molecular based inBozeman, MONTANA (USA)
The Borealis Arrestin Biosensors by Montana Molecular represent a cutting-edge tool in the realm of GPCR drug discovery, focusing on arrestin recruitment and signaling dynamics. These biosensors facilitate the continuous measurement of signaling activities in live cells, crucial for the development of precise pharmacological agents. The sensors are designed to ...
by:ImageProVision Technology Pvt. Ltd. based inPune, INDIA
This system improves the accuracy and efficiency of microscopic particle characterization, making it particularly useful in pharmaceutical applications such as new drug development, FDA approval processes, and ANDA filings. The software is user-friendly, flexible, and interactive, simplifying complex analysis tasks for professionals in the ...
Manufactured by:InSphero AG based inSchlieren, SWITZERLAND
When you’re ready, we deliver. InSphero assay-ready spheroid microtissues are engineered and certified for use in critical drug development applications, and validated to ensure uniform size, robust functionality, and reproducible results. We develop 3D InSight™ Microtissues using the most advanced 3D cell culture technologies ...